Novartis/NVS
US$102.57
-0.11%About Novartis
Ticker
Sector
Trading on
Industry
CEO
Employees
Headquarters
Novartis Metrics
US$226B
13.91
US$7.37
0.58
US$3.50
3.65%
Price and volume
Financial strength
Management effectiveness
Valuation
Growth
What the Analysts think about Novartis
Analyst Ratings
Price Targets
US$102.57
US$114.51
Novartis Financial Performance
Income Statement
Q1 24
QoQ growth
US$12B
2.92%
US$2.7B
-68.3%
22.17%
-69.21%
Novartis Earnings Performance
Earnings per share (EPS)
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
US$1.83
US$1.83
US$1.53
US$1.80
-
US$1.68
US$1.70
US$1.69
US$1.69
US$1.85
8.68%
7.86%
-9.2%
6.76%
-
Upcoming events
FAQs
What’s the current market cap for Novartis stock?
What is the P/E ratio for Novartis stock?
Does Novartis stock pay dividends?
Yes, the Novartis (NVS) stock pays dividends to shareholders. As of May 20, 2024, the dividend rate is $3.4987 and the yield is 3.65%. Novartis has a payout ratio of 77.34% on a trailing twelve-month basis.
When is the next Novartis dividend payment date?
The next Novartis (NVS) dividend payment date is unconfirmed.
What is the beta indicator for Novartis?
Novartis (NVS) has a beta rating of 0.58. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.
What is the Novartis stock price target?
The target price for Novartis (NVS) stock is $114.51, which is 11.64% above the current price of $102.57. This is an average based on projections from 8 analysts, and represents their view of what the stock price could be in 12 or 18 months. This should not be seen as investment advice - Lightyear does not carry out investment research.